Search Results 641-650 of 16346 for isotretinoin

  1. A Study to Investigate LYL797 in Adults With Solid Tumors - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or ...

  2. Birth control pill FAQ: Benefits, risks and choices - Mayo Clinic

    While you take the inactive pills, menstrual-like bleeding occurs. Today you have many more options — from regimens with 24 days of active pills and four days ...

  3. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

    About this study. This is a study of TRC105 in combination with standard dose pazopanib compared to single agent pazopanib in patients with angiosarcoma not ...

  4. Mayo Clinic

    Erin Turners e-Patient Success Story -- Youtube · More videos on YouTube · Double your impact! · About Mayo Clinic · Medical Professionals · Businesses · Students.

  5. Publications - Cindy A. Kermott, M.D., M.P.H. - Mayo Clinic

    Kermott CA, Schroeder DR, Kopecky SL, Behrenbeck TR. Cardiorespiratory Fitness and Coronary Artery Calcification in a Primary Prevention Population.

  6. A Randomized, Placebo-controlled, Double-blind, Multi-center Phase 2/3 Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients with Symptomatic Polycystic Liver Disease - Mayo Clinic

    A Randomized, Placebo-controlled, Double-blind, Multi-center Phase 2/3 Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in ...

  7. A Study Evaluating the Effectiveness and Safety of Axicabtagene Ciloleucel in Subjects with High-Risk Large B-Cell Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. A Trial of the Effectiveness, Safety, and Tolerability of a Single Oral Administration of CP101 for the Prevention of Recurrent Clostridioides difficile Infection (PRISM4) - Mayo Clinic

    After completing standard-of-care (SOC) CDI antibiotics for their most recent CDI recurrence, patients who meet all eligibility requirements will be randomized ...

  9. A Study to Test Sacituzumab Govitecan Therapy in Patients with HER2-Negative Breast Cancer and Brain Metastases - Mayo Clinic

    The purpose of this study is to analyze the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain ( ...

  10. Mayo Clinic

    Home · Charles Adler-Saliva Test for Parkinsons Disease-YouTube ...